Needham skeptical of potential Endo Health takeover Needham said it's skeptical of a possible Endo Health takeover after Reuters reported yesterday afternoon that the company is in talks to sell itself. Needham said it struggles to identify a natural strategic buyer, but says private equity could show interest. The firm keeps an Underperform rating on Endo Health.
News For ENDP From The Last 14 Days
Check below for free stories on ENDP the last two weeks.